Research ArticleGASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL
Cross-Talk between Farnesoid-X-Receptor (FXR) and Peroxisome Proliferator-Activated Receptor γ Contributes to the Antifibrotic Activity of FXR Ligands in Rodent Models of Liver Cirrhosis
Stefano Fiorucci, Giovanni Rizzo, Elisabetta Antonelli, Barbara Renga, Andrea Mencarelli, Luisa Riccardi, Antonio Morelli, Mark Pruzanski and Roberto Pellicciari
Journal of Pharmacology and Experimental Therapeutics October 2005, 315 (1) 58-68; DOI: https://doi.org/10.1124/jpet.105.085597
Stefano Fiorucci
Giovanni Rizzo
Elisabetta Antonelli
Barbara Renga
Andrea Mencarelli
Luisa Riccardi
Antonio Morelli
Mark Pruzanski
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleGASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL
Cross-Talk between Farnesoid-X-Receptor (FXR) and Peroxisome Proliferator-Activated Receptor γ Contributes to the Antifibrotic Activity of FXR Ligands in Rodent Models of Liver Cirrhosis
Stefano Fiorucci, Giovanni Rizzo, Elisabetta Antonelli, Barbara Renga, Andrea Mencarelli, Luisa Riccardi, Antonio Morelli, Mark Pruzanski and Roberto Pellicciari
Journal of Pharmacology and Experimental Therapeutics October 1, 2005, 315 (1) 58-68; DOI: https://doi.org/10.1124/jpet.105.085597
Research ArticleGASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL
Cross-Talk between Farnesoid-X-Receptor (FXR) and Peroxisome Proliferator-Activated Receptor γ Contributes to the Antifibrotic Activity of FXR Ligands in Rodent Models of Liver Cirrhosis
Stefano Fiorucci, Giovanni Rizzo, Elisabetta Antonelli, Barbara Renga, Andrea Mencarelli, Luisa Riccardi, Antonio Morelli, Mark Pruzanski and Roberto Pellicciari
Journal of Pharmacology and Experimental Therapeutics October 1, 2005, 315 (1) 58-68; DOI: https://doi.org/10.1124/jpet.105.085597
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement